Results

528.

Kocatürk, E.⁺, Al-Ahmad, M., Krause, K., Giménez-Arnau, A. M., Thomsen, S. F., Conlon, N., Marsland, A., Savk, E., Criado, R. F., Danilycheva, I., Fomina, D., Godse, K., Khoshkhui, M., Gelincik, A., Degirmentepe, E. .N, Demir, S., Ensina, L. F., Kasperska-Zajac, A., Rudenko, M., Valle, S., Medina, I., Bauer, A., Zhao, Z., Staubach, P., Bouillet, L., Küçük, Ö. S., Baygül, A., and Maurer, M.: Treatment patterns and outcomes in patients with chronic urticaria during pregnancy: results of PREG-CU, a UCARE study. J. Eur. Acad. Dermatol. Venereol. 2023: 37; 356-364. IF: 8.40

529.

Kocatürk, E.⁺, Thomsen, S. F., Al-Ahmad, M., Giménez-Arnau, A., Conlon, N., Savk, E., Criado, R. F., Danilycheva, I., Fomina, D., Khoshkui, M., Gelincik, A., Degirmentepe, E. N., Demir, S., Ensina, L. F., Kasperska-Zajac, A., Rudenko, M., Bauer, A., Medina, I., and Maurer, M.: Total IgE levels are linked to the course of chronic spontaneous urticaria during pregnancy. J. Allergy Clin. Immunol. Pract. 2023: 11; 350-353. IF: 8.20

530.

Hackler, Y., Siebenhaar, F., Maurer, M., and Muñoz-Roldan, M.⁺: Virus-infected mast cells directly activate virus-specific CD8⁺ T cells. Scand. J. Immunol. 2023: 98; e13272. IF: 4.10

531.

Bonnekoh, H., Butze, M., Spittler, S., Staubach, P., Weller, K., Scheffel, J., Maurer, M., and Krause, K.⁺: Inhibition of interleukin-1 with rilonacept is not effective in cold urticaria – results of a randomized, placebo-controlled study. Clin. Transl. Allergy 2023: 13; e12226. IF: 4.60

532.

Li, P. H.^+*, Pawankar, R.^+*, Thong, B. Y.-H., Fok, J. S., Chantaphakul, H., Hide, M., Jindal, A. K., Kang, H.-R., Latiff, A. H. A., Lobo, R. C. M., Munkhbayarlakh, S., Van Nguyen, D., Shyur, S.-D., Zhi, Y., and Maurer, M.: Epidemiology, management and treatment access of hereditary angioedema in the Asia Pacific region: outcomes from an international survey. J. Allergy Clin. Immunol. Pract. 2023: 11; 1253-1260. IF: 8.20

534.

Gotlib, J.^+*, Castells, M.^+*, Oude Elberink, H., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., Barete, S., Ustun, C., Schwartz, L., Ward, B. R., Schafhausen, P., Vadas, P., Bose, P., DeAngelo, D. J., Rein, L., Vachhani, P., Triggiani, M., Bonadonna, P., Rafferty, M., Butt, N. M., Oh, S. T., Wortmann, F., Ungerstedt, J., Guilarte, M., Taparia, M., Kuykendall, A. T., Yi, C. A., Ogbogu, P., Gaudy-Marqueste, C., Mattsson, M., Shomali, W., Giannetti, M. P., Bidollari, I., Lin, H.-M., Sullivan, E., Mar, B., Scherber, R., Roche, M., Akin, C., and Maurer, M.: Avapritinib versus placebo in indolent systemic mastocytosis. NEJM Evid. 2023: 2. IF: N/A

535.

536.

Church, M. K.⁺, Canonica, G. W., Kuna, P., Maurer, M., Mösges, R., Novak, Z., Papadopoulos, N. G., Rodriguez del Rio, P., and the Delphi Study Group: An international Delphi study on the burden of allergic rhinoconjunctivitis and urticaria and the role of bilastine among current treatment options. Expert Rev. Clin. Immunol. 2023: 19; 813-820. IF: 3.90

537.

Moñino-Romero, S., Kolkhir, P., Szépfalusi, Z., Schoepke, N., Metz, M., Asero, R., Ferrer, M., Giménez-Arnau, A., Grattan, C. E. H., Jakob, T., Konstantinou, G. N., Raap, U., Staubach, P., Zhang, K., Bindslev-Jensen, C., Daschner, A., Kinaciyan, T., Makris, M., Marrouche, N., Schmid-Grendelmeier, P., Sussman, G., Toubi, E., Maurer, M.⁺, and Altrichter, S.: In chronic spontaneous urticaria soluble FcεRI is elevated and linked to atopy and chronic inducible urticaria. Clin. Transl. Allergy. 2023: 13; e12272. IF: 4.60

538.

Lumry, W. R, Maurer, M., Weller, K., Riedl, M. A., Watt, M., Yu, M., Devercelli, G., Meunier, J., Banerji, A.: HELP OLE Study Group: Long-term lanadelumab treatment improves health-related quality of life in patients with hereditary angioedema. Ann. Allergy Asthma Immunol. 2023: 13; 101-108. IF: 5.80